These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 905760)

  • 41. [Soft tissue diagnosis on the extremities using soft tissue radiography. Part I. Indications and some technical aspects of low KeV radiography (author's transl)].
    Fischer E
    Radiologe; 1974 Oct; 14(10):454-6. PubMed ID: 4438635
    [No Abstract]   [Full Text] [Related]  

  • 42. [X-ray signs of acromegaly].
    Shimanovskaia KB; Grigor'eva I; Rokhlin GD
    Klin Med (Mosk); 1975 May; 52(5):105-6. PubMed ID: 1133976
    [No Abstract]   [Full Text] [Related]  

  • 43. Heterogeneity of circulating growth hormone in acromegaly.
    Dimond RC; Wartofsky L; Rosen SW
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1133-7. PubMed ID: 4214833
    [No Abstract]   [Full Text] [Related]  

  • 44. [Growth hormone liberation after TRH in patients with acromegaly].
    Morosini PP; Campanella N; Carletti P; Sturbini S; Testa I
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1239-42. PubMed ID: 6779828
    [No Abstract]   [Full Text] [Related]  

  • 45. Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly.
    Rubin AL; Levin SR; Bernstein RI; Tyrrell JB; Noacco C; Forsham PH
    J Clin Endocrinol Metab; 1973 Jul; 37(1):160-2. PubMed ID: 4577094
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical acromegaly with undetectable growth hormone and hyperprolactinemia.
    Valenta LJ; Elias AN
    J Natl Med Assoc; 1987 May; 79(5):555, 559-60. PubMed ID: 3586051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma growth hormone in the long-term follow-up of X-ray-treated and untreated acromegalics.
    Hunter WM; McGurk FM; McLelland J; Strong JA
    Proc R Soc Med; 1970 Mar; 63(3):223. PubMed ID: 5445552
    [No Abstract]   [Full Text] [Related]  

  • 48. Acromegaly with 'normal' growth hormone levels.
    Feingold KR; Lorenz TJ
    West J Med; 1985 Jan; 142(1):95-7. PubMed ID: 3976225
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: Prolactin concentrations in patients with acromegaly: relation to growth hormone levels before and after surgery.
    Franks S; Jacobs HS; Nabarro JD
    J Endocrinol; 1975 Jun; 65(3):25P-26P. PubMed ID: 1151225
    [No Abstract]   [Full Text] [Related]  

  • 50. [X-ray changes in the cardiovascular system in acromegaly].
    Edvabnaia EM; Kiandarian GG
    Vestn Rentgenol Radiol; 1978; (5):69-74. PubMed ID: 716206
    [No Abstract]   [Full Text] [Related]  

  • 51. [The radiological features of the distal tibio-fibular syndesmosis (author's transl)].
    Weissman JA; Lazis AK
    Rofo; 1980 Jul; 133(1):46-51. PubMed ID: 6451527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose suppression of serum growth hormone in the diagnosis of acromegaly.
    Earll JM; Sparks LL; Forsham PH
    JAMA; 1967 Aug; 201(8):628-30. PubMed ID: 5006772
    [No Abstract]   [Full Text] [Related]  

  • 53. [Secretory mode of GH in acromegaly--reactions to various stimuli].
    Onishi T; Azukizawa M; Hashimoto T; Miyai K; Kumahara Y
    Horumon To Rinsho; 1977 Jun; 25(6):619-23. PubMed ID: 560925
    [No Abstract]   [Full Text] [Related]  

  • 54. [Radioimmunologic determination of human growth hormones (STH) in the serum of 62 patients with acromegaly].
    Hackenberg K; Reinwein D; Horster FA
    Verh Dtsch Ges Inn Med; 1969; 75():769-71. PubMed ID: 5401633
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 56. [Parameters of human growth hormone (hGH) levels reflecting the activity of acromegaly].
    Jin ZM; Shi YF; Deng JY
    Zhonghua Nei Ke Za Zhi; 1987 May; 26(5):269-72, 318. PubMed ID: 3652832
    [No Abstract]   [Full Text] [Related]  

  • 57. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 58. [Endocrinological evaluation of sellar and suprasellar tumor cases (the eighth report)--on growth hormone secretion of acromegalic patients before treatment (author's transl)].
    Mori S; Uozumi T; Watanabe M; Takimoto N; Mogami H
    No Shinkei Geka; 1976 Jul; 4(7):649-61. PubMed ID: 986015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter: Growth hormone in acromegaly.
    Lancet; 1973 Oct; 2(7834):913. PubMed ID: 4126954
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of medroxyprogesterone acetate therapy on carbohydrate metabolism in acromegaly.
    Blum I; Karp M; Laron Z
    Isr J Med Sci; 1972 Jun; 8(6):881-2. PubMed ID: 5051830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.